Dermatology products are challenging to develop and manufacture with complexities arising from formulation & process development, stability and scale up. In addition, a majority of the dermatology products require expensive clinical studies, which act as a barrier to entry for a lot of companies. Such products offer a niche market opportunity for Solaris Pharma Corporation.

Solaris Pharma Corporation benefits from its technical expertise in the development of specialized generic & branded dermatology products. With its committed and well-trained scientific personnel, Solaris Pharma Corporation is currently developing several topical & transdermal products, which are in different stages of development.